Neuropsychopharmacology
- Disassociating drug active ingredients from inactive: ketamine-like synaptic effects of a ketamine excipient1 year ago
- How electroconvulsive therapy works in the treatment of depression: is it the seizure, the electricity, or both?1 year ago
- Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms1 year ago
- Therapeutic mechanisms of psychedelics and entactogens1 year ago
- Increasing ecological validity in neuropsychopharmacology research on the relationship between alcohol use and uncertain stressors1 year ago
- Neurobiology and treatment advances for prolonged grief disorder1 year ago
- Herpesviruses and neuropsychiatric disorders: overlooked adversaries or innocent bystanders?1 year ago
Journal of Psychopharmacology
- Evaluation of the effectiveness and acceptability of the long-acting oral antipsychotic penfluridol: Illustrative case series3 years ago
- Effects of 31 recombinant CYP2C19 variants on clomipramine metabolism in vitro3 years ago
- Utility of a controlled amphetamine withdrawal paradigm among adults who use methamphetamine: A pilot clinical trial3 years ago
- Relationship between depression, prefrontal creatine and grey matter volume3 years ago
- Intoxication without anticipation: Disentangling pharmacological from expected effects of alcohol3 years ago
- Aberrant inhibitory processing in the somatosensory cortices of cannabis-users3 years ago
- Cevimeline co-treatment attenuates olanzapine-induced metabolic disorders via modulating hepatic M3 muscarinic receptor: AMPKα signalling pathway in female rats3 years ago
European Neuropsychopharmacology
- A double-blind, randomized, placebo-controlled proof of concept study of the efficacy and safety of Lu AF11167 for persistent negative symptoms in people with schizophrenia2 years ago
- Digital tools for the assessment of pharmacological treatment for depressive disorder: State of the art2 years ago
- A pacemaker for happiness – Transcutaneous vagus nerve stimulation in depression2 years ago
- Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs2 years ago
- Corrigendum to “34th ECNP Congress – Lisbon 2021 Hybrid. [34th ECNP Congress – Lisbon 2021 Hybrid. 53S1. December 2021]” P.0576 Knockdown of 5-HT1A receptor silencer Freud-2 in the frontal cortex affected the behavior and the serotonin system in mice2 years ago
- Transcriptome meta-analysis of valproic acid exposure in human embryonic stem cells2 years ago
- Sodium nitroprusside enhances the antipsychotic-like effect of olanzapine but not clozapine in the conditioned avoidance response test in rats2 years ago